MedPath

Premature Coronary Atherosclerosis in Scleroderma

Completed
Conditions
Scleroderma
Registration Number
NCT00372398
Lead Sponsor
Tuen Mun Hospital
Brief Summary

The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.

Detailed Description

Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  1. Age >= 18 years.
  2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tuen Mun Hospital

🇭🇰

Hong Kong, Hong Kong

Tuen Mun Hospital
🇭🇰Hong Kong, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.